Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 231-233

  Ma, Yonggang ^a   Yabluchanskiy, Andriy ^a   Hall, Michael E ^a   Lindsey, Merry L ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Extracellular matrix; Inflammation; Intima media thickness; MCP 1; MMP 9; Proteomics

Indexed keywords

COLLAGEN; ELASTIN; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; MACROPHAGE; MIGRATION; NOTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOOTH MUSCLE FIBER;

BIOMARKERS; EXTRACELLULAR MATRIX; INFLAMMATION; INTIMA MEDIA THICKNESS; MCP-1; MMP-9; PROTEOMICS;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHEMOKINE CCL2; DISEASE PROGRESSION; HUMANS; INFLAMMATION; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL;

EID: 84891611324     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.09.013     Document Type: Note

References (24)

1. Gu L., Okada Y., Clinton S.K., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
2. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:2045-2051.
3. Sukhova G.K., Schonbeck U., Rabkin E., et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999, 99:2503-2509.
4. Tan C., Liu Y., Li W., et al. Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness. Atherosclerosis 2014, 232:199-203.
5. Lemaitre V., Kim H.E., Forney-Prescott M., Okada Y., D'Armiento J. Transgenic expression of matrix metalloproteinase-9 modulates collagen deposition in a mouse model of atherosclerosis. Atherosclerosis 2009, 205:107-112.
6. Halade G.V., Jin Y.F., Lindsey M.L. Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther 2013, 139:32-40.
7. Wagsater D., Zhu C., Bjorkegren J., Skogsberg J., Eriksson P. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse. Int J Mol Med 2011, 28:247-253.
8. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005, 85:1-31.
9. Gough P.J., Gomez I.G., Wille P.T., Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. JClin Invest 2006, 116:59-69.
10. Stintzing S., Heuschmann P., Barbera L., et al. Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis. Ann Vasc Surg 2005, 19:310-319.
11. Galis Z.S., Johnson C., Godin D., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002, 91:852-859.
12. Ducharme A., Frantz S., Aikawa M., et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. JClin Invest 2000, 106:55-62.
13. Zamilpa R., Ibarra J., De Castro Bras L.E., et al. Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. JMol Cell Cardiol 2012, 53:599-608.
14. Cushing S.D., Berliner J.A., Valente A.J., et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990, 87:5134-5138.
15. Gosling J., Slaymaker S., Gu L., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. JClin Invest 1999, 103:773-778.
16. Tanaka E., Shimokawa H., Kamiuneten H., et al. Disparity of MCP-1 mRNA and protein expressions between the carotid artery and the aorta in WHHL rabbits: one aspect involved in the regional difference in atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:244-250.
17. Hoogeveen R.C., Morrison A., Boerwinkle E., et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis 2005, 183:301-307.
18. Yuasa S., Maruyama T., Yamamoto Y., et al. MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract 2009, 86:193-198.
19. Hamano Y., Zeisberg M., Sugimoto H., et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003, 3:589-601.
20. Trial J., Rossen R.D., Rubio J., Knowlton A.A. Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes. Exp Biol Med (Maywood) 2004, 229:538-545.
21. Yabluchanskiy A., Li Y., De Castro Bras L.E., Hakala K., Weintraub S.T., Lindsey M.L. Proteomic analysis of the left ventricle post-myocardial infarction to identify invivo candidate matrix metalloproteinase substrates. Methods Mol Biol 2013, 1066:185-199.
22. De Castro Bras L.E., Ramirez T.A., DeLeon-Pennell K.Y., et al. Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix. JProteomics 2013, 86:43-52.
23. Wang Y., Yang T., Ma Y., et al. Mathematical modeling and stability analysis of macrophage activation in left ventricular remodeling post-myocardial infarction. BMC Genomics 2012, 13(Suppl.6):S21.
24. Yang T., Chiao Y.A., Wang Y., et al. Mathematical modeling of left ventricular dimensional changes in mice during aging. BMC Syst Biol 2012, 6(Suppl.3):S10.